Background The efficacy and side-effect profile of ulipristal acetate as compared with those
of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are …

Background The efficacy and safety of oral ulipristal acetate for the treatment of symptomatic
uterine fibroids before surgery are uncertain. Methods We randomly assigned women with …

Objective To investigate the efficacy and safety of repeated 12-week courses of 5 or 10 mg
daily of ulipristal acetate for intermittent treatment of symptomatic uterine fibroids. Design …

Uterine fibroids are the most common benign tumors of the female genital tract. The
management of symptomatic fibroids has traditionally been surgical; however, alternative …

Objective To investigate the efficacy and safety of repeated 12-week courses of 5 or 10 mg
daily ulipristal acetate for intermittent treatment of symptomatic uterine fibroids. Design …

Objective To investigate the efficacy and safety of ulipristal acetate (UPA) for long-term
treatment of symptomatic uterine fibroids. Design Repeated intermittent open-label UPA …

Objective To study the pregnancy rate after ulipristal acetate (UPA) therapy for fibroids.
Design Retrospective analysis of a series of 52 patients prospectively included in the …

Objective To assess long term safety of extended repeated 3-month courses of ulipristal
acetate (UPA) 10 mg/day, for up to 8 courses, with focus on endometrial and laboratory …

Background Uterine fibroids are hormone-responsive neoplasms that are associated with
heavy menstrual bleeding. Elagolix, an oral gonadotropin-releasing hormone antagonist …

Background Uterine fibroids are a common cause of heavy menstrual bleeding and pain.
Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone …